Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05009251 · ClinicalTrials.gov registry record · NA

Using Explainable AI Risk Predictions to Nudge Influenza Vaccine Uptake

A NA study, sponsored by National Bureau of Economic Research.

Completed
Registry status
NA
Development phase
45,061
Enrollment target

NCT05009251 is a NA study that has completed, run by National Bureau of Economic Research. The registered enrollment target is 45,061 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05009251, a NA study, has completed, sponsored by National Bureau of Economic Research.

COMPLETED
Registry status
NA
Development phase
45,061 participants
Enrollment target

Study Summary

The study team previously demonstrated that patients are more likely to receive flu vaccine after learning that they are at high risk for flu complications. Building on this past work, the present study will explore whether providing reasons that patients are considered high risk for flu complications (a) further increases the likelihood they will receive flu vaccine and (b) decreases the likelihood that they receive diagnoses of flu and/or flu-like symptoms in the ensuing flu season. It will also examine whether informing patients that their high-risk status was determined by analyzing their medical records or by an artificial intelligence (AI) / machine-learning (ML) algorithm analyzing their medical records will affect the likelihood of receiving the flu vaccine or diagnoses of flu and/or flu-like symptoms.

Interventions

  • BEHAVIORAL Reminder
  • BEHAVIORAL Risk reduction
  • BEHAVIORAL Medical records-based recommendation
  • BEHAVIORAL Algorithm-based recommendation

Trial Details

FieldValue
Enrollment Target 45,061 participants
Start Date 2021-09-09
Est. Completion 2022-07-31
Phase NA

What the Registry Record Tells You About NCT05009251

The ClinicalTrials.gov registry entry for NCT05009251 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45,061 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Bureau of Economic Research, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 4 interventions - of which Reminder is the first listed.

NCT05009251 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05009251 about?

NCT05009251 is a clinical study titled "Using Explainable AI Risk Predictions to Nudge Influenza Vaccine Uptake". The study team previously demonstrated that patients are more likely to receive flu vaccine after learning that they are at high risk for flu complications. Building on this past work, the present study will explore whether providing reasons that patients are considered high risk for flu complicatio...

What is the current status of trial NCT05009251?

This trial is currently completed. It is a NA study. The enrollment target is 45,061 participants. The study started on 2021-09-09. Estimated completion is 2022-07-31.

What interventions are being tested in trial NCT05009251?

The interventions under investigation include: Reminder (BEHAVIORAL), Risk reduction (BEHAVIORAL), Medical records-based recommendation (BEHAVIORAL), Algorithm-based recommendation (BEHAVIORAL).

Who is sponsoring clinical trial NCT05009251?

This trial is sponsored by National Bureau of Economic Research, which has 14 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.